CORPORATE GOVERNANCE | 2026-10-02

An Informed Decision: The Duty of Care and the Lesson of Smith v. Van Gorkom

A board can be liable for approving a merger — even at a premium price — if it did so without being adequately informed. Van Gorkom is the case that put teeth in the duty of care.

Directors are protected by the business judgment rule — but only when their decisions are informed. The case that proved how real that requirement is remains one of the most studied in corporate law: Smith v. Van Gorkom. There, the Delaware Supreme Court he

Approving a deal at a good price is not enough — the board must be informed. Smith v. Van Gorkom, 488 A.2d 858 (Del. 1985), held directors personally liable for a hasty merger approval, and its lesson about the duty of care still governs boardrooms today. The case transformed how public-company directors deliberate, created the market for formal fairness opinions, and prompted the legislature to enact the exculpation statute that now limits director liability for care-based claims. This guide explains the duty of care, what happened in Van Gorkom, the standard courts apply, the better process the decision produced, and how exculpation works.

The Duty of Care and the Business Judgment Rule

Directors owe the corporation and its shareholders a duty of care — to act on an informed basis, with the care an ordinarily prudent person would use under similar circumstances. The business judgment rule is a presumption that, in making a decision, directors acted on an informed basis, in good faith, and in the honest belief that the action was in the company's best interest. When the presumption holds, courts will not second-guess the substance of the decision, even one that turns out badly.

But the presumption is not automatic. It applies only if the decision was in fact informed. If directors fail to inform themselves of all material information reasonably available before acting, they forfeit the protection of the rule, and the decision becomes vulnerable to challenge. The duty of care is therefore primarily about process: the steps the board took to understand what it was deciding.

What Happened in Van Gorkom

In Smith v. Van Gorkom, the board of Trans Union Corporation approved a cash-out merger under circumstances the court found deeply deficient:

the board approved the deal at a hastily called meeting lasting roughly two hours, without prior notice of the merger's purpose;
it relied on a brief oral presentation by the CEO and did not read the merger agreement before approving it;
it had no written fairness opinion and little independent analysis of the company's intrinsic value; and
the merger price, though a premium over the stock's market price, was essentially derived from a per-share figure the CEO had suggested as a leveraged-buyout number, without the board independently valuing the company or testing the market.

The Delaware Supreme Court held that the directors had breached their duty of care by failing to inform themselves adequately before approving the merger, and that they were not protected by the business judgment rule. The decision was notable precisely because the outside directors were experienced and the price exceeded market — yet the process was so thin that it could not support an informed judgment.

The Standard: Gross Negligence

Van Gorkom clarified that the standard for a duty-of-care breach in the decision-making context is gross negligence — not ordinary negligence. Directors are not liable merely because a decision produces a poor result, or because they made a reasonable error of business judgment. The question is whether the board's failure to become informed was grossly negligent: whether it skipped the steps a reasonable board would take to gather and consider the material information available to it.

This standard protects good-faith business decisions while still demanding real diligence on matters of fundamental importance, such as the sale of the company. The focus stays on the process: did the directors take the steps necessary to make an informed decision, or did they rubber-stamp a transaction they did not understand?

Why a Premium Price Did Not Save the Board

A striking feature of Van Gorkom is that the merger price was a premium over the market price — yet the board was still liable. The lesson is that the duty of care is about the decision-making process, not merely the outcome. A board cannot approve a transaction without understanding the company's value and the deal's material terms, even if the price looks attractive, because without that information the board has no way to know whether the price is actually fair or whether a better alternative exists.

Market price is not the same as intrinsic value. A premium over a depressed or thinly analyzed market price may still undervalue the company. Only an informed board — one that has considered valuation, alternatives, and the agreement's terms — can responsibly conclude that a given price captures the best value reasonably available.

The Practical Response: Better Process

Van Gorkom reshaped how boards approve transactions. To satisfy the duty of care, boards now routinely:

allow adequate time to consider a transaction, with meetings scheduled so directors can prepare, rather than acting under artificial deadline pressure;
obtain and review a written fairness opinion from a qualified, independent financial advisor;
review the actual agreement and understand its material terms, including price, conditions, and deal protections;
consider the company's intrinsic value and reasonable strategic alternatives, including remaining independent;
engage experienced legal and financial advisors and ask questions; and
document the deliberations in minutes that reflect the information considered and the reasons for the decision.

These practices build the record that the decision was informed — the record on which the business judgment rule's protection ultimately depends.

The Role of Fairness Opinions and Advisors

One lasting consequence of Van Gorkom was the near-universal use of formal fairness opinions in significant transactions. A fairness opinion is a financial advisor's view that the consideration in a transaction is fair, from a financial point of view, to the company's stockholders. It is not a guarantee of the best price, and directors may not treat it as a substitute for their own informed judgment — the board must understand the analysis and the assumptions behind it. But a well-supported opinion from a qualified advisor is strong evidence that the board gathered and considered the material financial information. DGCL § 141(e) further protects directors who rely in good faith on reports and opinions presented by advisors selected with reasonable care.

Exculpation — DGCL § 102(b)(7)

Van Gorkom's imposition of personal liability on directors for a care breach prompted a swift legislative response: exculpation statutes. In Delaware, DGCL § 102(b)(7) permits a corporation to include a charter provision exculpating directors from monetary liability for breaches of the duty of care. The exculpation is significant but limited. It does not reach breaches of the duty of loyalty, acts or omissions not in good faith, intentional misconduct or knowing violations of law, improper personal benefit, or (for the historical director provision) unlawful dividends. It also does not bar injunctive relief; it addresses money damages.

Most Delaware corporations adopted § 102(b)(7) provisions, which substantially limit directors' monetary exposure for care-based claims. The duty of care itself remains fully in force — an exculpation clause affects the remedy, not the duty — so a board still must run a careful process, both because loyalty and good-faith claims are not exculpated and because injunctive challenges to a pending deal turn on the quality of the board's conduct.

A Step-by-Step Model of an Informed Board Process

The practical teaching of Van Gorkom is best captured as a sequence of steps a board should work through before approving a significant transaction. While no checklist guarantees the business judgment rule's protection, a board that follows a disciplined process builds the record that the decision was informed:

Advance notice and materials. Directors receive notice of the transaction's purpose and the key materials — a draft agreement, a summary of terms, and the advisor's analysis — with enough lead time to read and digest them before the meeting.
Engagement of qualified advisors. The board retains independent financial and legal advisors, selected with reasonable care, and understands their mandate.
Valuation and alternatives. The board considers the company's intrinsic value using more than a single metric, and it weighs realistic alternatives, including remaining independent or pursuing other counterparties.
Review of terms. The board understands the material terms — price, form of consideration, conditions, deal protections, and the treatment of management — and asks questions about anything unclear.
Fairness opinion. The board receives and understands a fairness opinion, including its assumptions and limitations, rather than treating the bottom-line conclusion as a substitute for its own judgment.
Deliberation and documentation. The board deliberates over an appropriate period and records its deliberations in minutes that reflect the information considered and the reasons for the decision.

The point is not that a board must take a fixed amount of time or follow a rigid script. It is that the directors must actually inform themselves of the material information reasonably available before committing the company to a fundamental transaction.

Common Mistakes That Create Care Exposure

Several recurring errors echo the failures Van Gorkom identified. The first is acting under artificial time pressure — approving a deal in a single compressed meeting because a counterparty or an executive insists on speed. Urgency is sometimes genuine, but a board should test whether a deadline is real and, if it is, make sure it still allows the board to inform itself.

A second error is over-reliance on a single person's say-so, particularly an executive with a personal stake in the transaction. The Van Gorkom board effectively adopted a price the CEO had generated without independently testing it; a board should understand where the numbers come from and whether the proponent has a conflict.

A third error is treating a premium as dispositive. A premium over market tells the board that the offer exceeds the current trading price, but not whether it reflects the company's intrinsic value or the best value reasonably available. The board must still understand value and alternatives.

A fourth error is thin documentation. Even a board that deliberates carefully can struggle to defend its decision if the minutes are sparse. Contemporaneous records of the information presented and the reasons for the decision are among the board's most important defensive assets.

What Van Gorkom Means for Shareholders

For shareholders, Van Gorkom is more than a historical landmark; it defines the kind of claim that can survive against directors. Because most Delaware charters contain a § 102(b)(7) exculpation provision, a pure duty-of-care claim for money damages against directors will usually be dismissed. That makes the process record doubly important to a plaintiff: a challenge is far more viable if the facts suggest not merely carelessness but a breach of the duty of loyalty or a failure to act in good faith — conduct that exculpation does not cover — or if the plaintiff seeks injunctive relief against a pending deal rather than damages.

Shareholders evaluating a transaction should therefore scrutinize how the board ran its process: whether it had enough time and information, whether it used independent advisors, whether conflicts were managed, and whether the proxy disclosure fully describes the process. A thin or conflicted process is both a potential breach and, often, a disclosure problem that can support a pre-closing challenge.

The Line Between Care and Loyalty

One reason Van Gorkom continues to matter is that it marks the boundary between two different fiduciary duties with very different consequences. A duty-of-care breach concerns how well the board informed itself and deliberated; in Delaware it is measured by gross negligence and, crucially, it can be exculpated by a § 102(b)(7) charter provision. A duty-of-loyalty breach, by contrast, concerns whether directors acted in their own interest or in bad faith rather than in the interest of the company and its stockholders; it cannot be exculpated, and it can expose directors to personal liability for damages.

The distinction shapes litigation strategy on both sides. A plaintiff who can only show a sloppy but good-faith process will usually be defeated by exculpation. A plaintiff who can plead facts suggesting that directors consciously disregarded their responsibilities, were dominated by a conflicted insider, or stood to gain personally may state a non-exculpated claim that survives. For directors, the lesson is that a careful, well-advised, well-documented process protects against care claims and also helps rebut any inference of disloyalty or bad faith, because a thin process is sometimes the circumstantial evidence from which a court infers a deeper problem.

Good faith occupies the space between the two duties. The Delaware courts have treated a sustained or systematic failure to exercise oversight, or an intentional dereliction of duty, as a failure to act in good faith that implicates loyalty and falls outside exculpation. While Van Gorkom itself was decided as a care case, its emphasis on process foreshadowed the modern understanding that how a board behaves — attentiveness, information, deliberation — is relevant across all of these overlapping standards.

For a board approving a transaction today, the practical conclusion is straightforward: a disciplined process is the single most effective protection available. It earns the business judgment rule's deference where it applies, it anchors the defense of an exculpated care claim, and it undercuts attempts to recast an informed, good-faith decision as disloyalty or bad faith. The cost of good process is modest; the cost of the hurried approval in Van Gorkom was personal liability for experienced directors.

A Note on Jurisdiction

Van Gorkom and § 102(b)(7) are Delaware law and govern Delaware corporations. California corporations are governed by California law, which likewise imposes a duty of care on directors (see Cal. Corp. Code § 309) and permits certain charter limitations on director liability (Cal. Corp. Code § 204); California courts often find Delaware's corporate jurisprudence persuasive. The state of incorporation determines the governing standards and the availability of exculpation, so identifying the applicable law is the necessary starting point.

Frequently Asked Questions

What is the duty of care?

The directors' duty to act on an informed basis, with the care an ordinarily prudent person would use; the business judgment rule protects informed, good-faith decisions but applies only when the board actually informed itself.

What did Van Gorkom decide?

That a board breached its duty of care by approving a cash-out merger without adequate information, in a hurried two-hour process, without reading the agreement or obtaining a fairness opinion — even though the price was a premium over market.

What is the standard for a care breach?

Gross negligence in the decision-making process — not simple negligence and not a mere bad outcome. The inquiry centers on whether the board took the steps a reasonable board would take to become informed.

Why didn't the premium price protect the board?

Because the duty of care is about process. Without understanding the company's intrinsic value and the deal's terms, the board could not know whether the premium price was actually fair or whether a better alternative existed.

What is a fairness opinion and is it required?

A financial advisor's opinion that the consideration is fair, from a financial point of view, to stockholders. It is not strictly required, but it has become standard practice because it helps show the board considered the material financial information. It does not replace the board's own informed judgment.

What is DGCL § 102(b)(7)?

A Delaware statute allowing a charter to exculpate directors from monetary liability for duty-of-care breaches. It does not cover loyalty breaches, bad faith, intentional misconduct, or improper personal benefit, and it does not bar injunctive relief.

Can directors rely on advisors?

Yes. Under DGCL § 141(e), directors may rely in good faith on reports, opinions, and information from officers and from legal and financial advisors selected with reasonable care, provided the board still exercises its own informed judgment.

Does this apply to California corporations?

Van Gorkom is Delaware law. California corporations are governed by California law, which also imposes a duty of care and allows certain liability limitations. The state of incorporation controls which standards apply.

Related Securities & Governance Guides

Talk to a Corporate Attorney About Board Decisions

Whether you are a director approving a transaction or a shareholder questioning one, the duty of care turns on the quality of the board's process. A well-documented, well-advised deliberation is the best protection; a hurried, uninformed approval is the risk Van Gorkom made famous. Trembach Law Firm advises on M&A and corporate governance. Call (818) 514-7680.

Contact Trembach Law Firm at (818) 514-7680 for a confidential consultation.

Trembach Law Firm | 27001 Agoura Road, Suite 350, Calabasas, CA 91301